| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIODELIVERY SCIENCES INTL IN | 209,500 | 943,000 | 0.46% | Put | |
| 2 | SCYNEXIS INC | 337,177 | 1,359,000 | 0.67% | ||
| 3 | NEURODERM LTD | 119,781 | 1,691,000 | 0.83% | ||
| 4 | REGENXBIO INC COM | 156,741 | 1,693,000 | 0.83% | ||
| 5 | Anacor Pharmaceuticals Inc | 31,000 | 1,996,000 | 0.98% | Put | |
| 6 | BIODELIVERY SCIENCES INTL IN | 743,395 | 2,401,000 | 1.18% | ||
| 7 | NEXVET BIOPHARMA PUB LTD CO | 887,801 | 2,930,000 | 1.43% | ||
| 8 | OREXIGEN THERAPEUTICS INC COM | 6,462,080 | 3,636,000 | 1.78% | ||
| 9 | ARDELYX INC COM | 468,297 | 3,639,000 | 1.78% | ||
| 10 | ACCELERON PHARMA INC | 174,089 | 4,594,000 | 2.25% | ||
| 11 | ZAFGEN INC COM | 1,422,273 | 9,501,000 | 4.65% | ||
| 12 | NANOSTRING TECHNOLOGIES INC | 659,486 | 10,037,000 | 4.91% | ||
| 13 | AERIE PHARMACEUTICALS INC COM | 949,372 | 11,544,000 | 5.65% | ||
| 14 | ALDER BIOPHARMACEUTICALS INC | 530,416 | 12,990,000 | 6.36% | ||
| 15 | REGULUS THERAPEUTICS INC COM | 2,038,939 | 14,130,000 | 6.92% | ||
| 16 | ADAPTIMMUNE THERAPEUTICS PLC | 1,761,567 | 14,322,000 | 7.01% | ||
| 17 | EPIZYME INC COM | 1,191,995 | 14,447,000 | 7.07% | ||
| 18 | ADURO BIOTECH INC | 1,322,916 | 16,947,000 | 8.29% | ||
| 19 | UNIVERSAL AMERN CORP NEW | 2,814,883 | 20,098,000 | 9.84% | ||
| 20 | AIMMUNE THERAPEUTICS INC COM | 4,087,900 | 55,432,000 | 27.13% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-099539, filed 2016.05.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
